Copyright 1999 American Medical Association.
All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: The
review of the current pharmacotherapy of tobacco smoking cessation by
Dr Hughes and colleagues1 emphasizes that NRT and bupropion
are more effective than a placebo. As expected, the 6-month quit rates
using nicotine gum and patch in special tobacco cessation clinics (Table 2
in Hughes et al) are better than those with nicotine gum and
patch but minimal contact with health care personnel
(Table 1 in Hughes
et al). Why is nicotine replacement, even with health care professional
support, so minimally effective? Even with the best behavioral therapy
and pharmacotherapy now available, only 1 of 3 tobacco smokers who
desire to quit is able to do so at the end of 6 months.1
Domino EF. Adding Behavioral Therapy to Medication for Smoking Cessation. JAMA. 1999;281(21):1983–1985. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-21-jbk0602
Customize your JAMA Network experience by selecting one or more topics from the list below.